-
EP4071174
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4071174
| EP4071174 - METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.04.2023 Database last updated on 20.12.2024 | |
| Former | The application has been published Status updated on 09.09.2022 | Most recent event Tooltip | 03.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | For all designated states The United States of America, as Represented By the Secretary, Department of Health and Human Services National Institutes of Health Office of Technology Transfer 6701 Rockledge Drive Suite 700, MSC 7788 Bethesda, MD 20892 / US | [2022/41] | Inventor(s) | 01 /
BARRY, Simon Cambridge, CB4 0WG / GB | 02 /
KENDREW, Jane Cheshire, SK10 4TG / GB | 03 /
HO, Tony Gaithersburg, 20878 / US | 04 /
WEDGE, Stephen Cambridge, CB21 6GH / GB | 05 /
IVY, Susan Bethesda, 20892-7660 / US | 06 /
KOHN, Elise Bethesda, 20892-7660 / US | 07 /
LEE, Jung-Min Bethesda, 20892-7660 / US | [2022/41] | Representative(s) | Finnegan Europe LLP 1 London Bridge London SE1 9BG / GB | [2022/41] | Application number, filing date | 21211394.8 | 14.02.2017 | [2022/41] | Priority number, date | US201662295421P | 15.02.2016 Original published format: US 201662295421 P | [2022/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4071174 | Date: | 12.10.2022 | Language: | EN | [2022/41] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.09.2022 | Classification | IPC: | C07K16/28, G01N33/574, A61K38/00, A61K48/00, A61K39/395, A61P35/00, A61K31/502, A61K31/506, A61K45/06, A61P43/00, A61P9/10 | [2022/41] | CPC: |
C07K16/2827 (EP);
A61K31/517 (KR,US);
A61K31/502 (EP,KR,US);
A61K31/506 (EP);
A61K39/39558 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61K48/00 (EP);
A61P35/00 (EP,KR);
A61P43/00 (EP);
| C-Set: |
A61K31/502, A61K2300/00 (EP);
A61K31/506, A61K2300/00 (EP);
A61K39/39558, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/20] |
| Former [2022/41] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 30.11.2021 | ME | 30.11.2021 | Validation states | MA | 30.11.2021 | MD | 30.11.2021 | Title | German: | VERFAHREN MIT FIXER INTERMITTIERENDER DOSIERUNG VON CEDIRANIB | [2022/41] | English: | METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB | [2022/41] | French: | PROCÉDÉS COMPRENANT UN DOSAGE INTERMITTENT ET FIXE DE CEDIRANIB | [2022/41] | Examination procedure | 11.04.2023 | Amendment by applicant (claims and/or description) | 11.04.2023 | Examination requested [2023/20] | 11.04.2023 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP17753704.0 / EP3417294 | Fees paid | Renewal fee | 30.11.2021 | Renewal fee patent year 03 | 30.11.2021 | Renewal fee patent year 04 | 30.11.2021 | Renewal fee patent year 05 | 14.01.2022 | Renewal fee patent year 06 | 03.01.2023 | Renewal fee patent year 07 | 03.01.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2006035203 (ASTRAZENECA AB [SE], et al); | by applicant | WO9902166 | WO0040529 | WO0041669 | WO0047212 | WO0192224 | WO0194341 | WO0204434 | WO0208213 | US7074800 | US8779108 | US8859570 | US9493565 |